Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, July 14, 2016

Snus (Swedish smokeless tobacco) use and risk of stroke: Pooled Analyses of Incidence and Survival

I wonder if this would be a good nicotine delivery system for better recovery. I probably plan on using nicotine patches. Ask your doctor which delivery system is best for you.

Study explores nicotine patch to treat memory loss

Too bad the nicotine gum got cancelled.

1.  Nicotine Holds Promise for Stronger Stroke Recovery
2.  Nicotine Patch Appears To Help Mild Cognitive Loss

3.  A Nicotine Patch a Day Keeps the Cognitive Impairment Away
4. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease
5. Nicotinic receptors in aging and dementia
6. nicotine and stroke rehab

 

http://www.mdlinx.com/internal-medicine/medical-news-article/2014/02/21/stroke/5115410/?
Snus is a moist smokeless tobacco product with a high nicotine content. Its use has a short–term effect on the cardiovascular system, but the relationship between snus use and stroke is unclear. The aim of this study was to assess the associations between use of snus and incidence of and survival after stroke, both overall and according to subtypes. Use of snus was not associated with the risk of stroke. Hence, nicotine is unlikely to contribute importantly to the pathophysiology of stroke. However, case fatality was increased in snus users, compared to non–users, but further studies are needed to determine any possible causal mechanisms.

Methods

  • Pooled analyses of eight Swedish prospective cohort studies were conducted, including 130 485 men who never smoked.
  • estimated hazard ratios (HRs) with 95% confidence intervals (CIs) of incidence and death after diagnosis using Cox proportional hazard regression models, and case fatality and survival using logistic regression and Kaplan–Meier methods, respectively.

Results

  • No associations were observed between the use of snus and the risk of overall stroke (HR 1.04, 95% CI 0.92–1.17) or of any of the stroke subtypes.
  • The odds ratio (OR) of 28-day case fatality was 1.42 (95% CI 0.99–2.04) among users of snus who had experienced a stroke, and the HR of death during the follow-up period was 1.32 (95% CI 1.08–1.61).
Go to PubMed Go to Abstract Print Article Summary Cat 2 CME Report

No comments:

Post a Comment